Cart
sales@molnova.com
(S,R,S)-AHPC-PEG1-N3
CAS No. 2101200-09-1
(S,R,S)-AHPC-PEG1-N3( VH032-PEG1-N3 | VHL Ligand-Linker Conjugates 9 | E3 ligase Ligand-Linker Conjugates 3 )
Catalog No. M26949 CAS No. 2101200-09-1
(S,R,S)-AHPC-PEG1-N3 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 1-unit PEG linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 95 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | 728 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S,R,S)-AHPC-PEG1-N3
-
NoteResearch use only, not for human use.
-
Brief Description(S,R,S)-AHPC-PEG1-N3 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 1-unit PEG linker used in PROTAC technology.
-
Description(S,R,S)-AHPC-PEG1-N3 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 1-unit PEG linker used in PROTAC technology.
-
In Vitro——
-
In Vivo——
-
SynonymsVH032-PEG1-N3 | VHL Ligand-Linker Conjugates 9 | E3 ligase Ligand-Linker Conjugates 3
-
PathwayOthers
-
TargetOther Targets
-
RecptorM. incognita
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2101200-09-1
-
Formula Weight557.67
-
Molecular FormulaC26H35N7O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (179.32 mM)
-
SMILESO=C(N[C@@H](C(C)(C)C)C(N(C[C@H](O)C1)[C@@H]1C(NCC2=CC=C(C(SC=N3)=C3C)C=C2)=O)=O)COCCN=[N+]=[N-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ruanpanun P, et al. Nematicidal activity of Fervenulin isolated from a nematicidal actinomycete,
molnova catalog
related products
-
Lin28-let-7a antagon...
Lin28-let-7a antagonist 1, with an IC50 of 4.03 μM for Lin28A-let-7a-1 interaction,and shows a clear antagonistic effect against the Lin28-let-7a interaction.
-
I-BET567
I-BET567, a potent pan-BET inhibitor with oral activity, demonstrates pIC50 values of 6.9 and 7.2 for BRD4 BD1 and BD2, respectively. This compound has exhibited efficacy in mouse models of oncology and inflammation .
-
Mogroside III-A1
Mogroside III-A1 is a triterpenoid glycoside from Siraitia grosvenorii Swingle. Mogroside III-A1 a nonsugar sweetener.
